U.S. Markets closed

BofA Reaches 52-Week High

Zacks Equity Research

Shares of Bank of America Corporation (BAC) hit a new 52-week high, touching $15.30 in the first half of the trading session on Nov 19. However, the stock closed the session at $15.20, which reflects a solid year-to-date return of 26.7%. The trading volume for the session was 160.6 million shares.

Despite the strong price appreciation, this Zacks Rank #3 (Hold) banking giant has considerable upside left, given its positive estimate revision over the last 30 days and expected year-over-year earnings growth of 8.25% for 2013.

Growth Drivers

BofA’s impressive price performance reflects strong third-quarter 2013 results comprising a positive earnings surprise of 11.1%. Additionally, the company continues to strengthen its balance sheet position as reflected in its improved capital ratios.

On Oct 16, BofA declared third-quarter earnings of 20 cents per share, beating the Zacks Consensus Estimate of 18 cents. Results were aided by substantial reduction in the provision for credit losses and lower non-interest expenses.

Non-interest expenses were $16.4 billion, down 7% from $17.5 billion in the year-ago quarter. Though BofA has been continuously facing litigations, its cost containment program is helping it manage the legal expenses to a large extent.

Provision for credit losses decreased 83% year over year to $296 million. As of Sep 30, 2013, nonperforming loans, leases and foreclosed properties ratio was 2.17%, down 64 bps year over year.

Moreover, BofA has delivered 3 positive earnings surprises in the last 4 quarters with an average beat of 30.13%.

Estimate Revisions Show Potency

In the last 30 days, the Zacks Consensus Estimate for 2013 increased 1.1% to 90 cents per share. However, for 2014, the Zacks Consensus Estimate remained unchanged at $1.33 per share over the same time frame.

Better performing major regional banks worth considering include BankUnited, Inc. (BKU), Fifth Third Bancorp (FITB) and KeyCorp. (KEY). All these stocks carry a Zacks Rank #2 (Buy).

Read the Full Research Report on KEY
Read the Full Research Report on FITB
Read the Full Research Report on BAC
Read the Full Research Report on BKU

Zacks Investment Research